The Patent Finder

Rodos Biotarget GmbH

Also on record
Records under this name other than patents Rodos Biotarget GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 2 of 2 · Back to Rodos Biotarget GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,059,475Targeted Nanocarriers for Targeted Drug Delivery of Gene Therapeutics
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,357,457Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
Term ended
Term ended Sep 17, 2024 · USPTO record
Term endedTerm ended Sep 17, 2024USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited